N4 Pharma. N4 Pharma Announces Collaboration with SRI to Target and Treat Cells in the Human Body that Have Been Previously Unreachable. Press Release. Apr. 25, 2024.
The majority of PMCs/PMRs are proceeding according to schedule.
Mary Van Gaasbeck, technical services specialist, LS Equipment and Services, at STERIS Life Sciences, notes that automation ...
Andreas Frerix, product management director for Quattroflow at PSG Biotech, discussed the advantages and new challenges SUTs ...
Pharmaceutical Technology® spoke with Nicole Hunter, Watson-Marlow Fluid Technology Solutions’ head of Global WMArchitect, ...
Susan Schniepp, distinguished fellow, Regulatory Compliance Associates, and co-chair of board of directors, Parenteral Drug ...
Engineering & Product Management for Malema at PSG Biotech, shared insights at on how current industry trends are shaping the ...
Regulations for mRNA products are evolving as the market for mRNA expands. The development of effective vaccines to combat COVID-19 has showcased the potential of messenger RNA (mRNA) technology, ...
At INTERPHEX, Bill Whitford, Strategic Solutions leader at Arcadis, discusses the progress made in 3D bioprinting toward ...
Pharmaceutical Technology sat down with Christa Myers of CRB Group and Nadiyra Walker Speight of Fujifilm Diosynth ...
Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences, talks about the company's services and how they relate to ...
New regulations, including those put forth by Annex 1, require many pharmaceutical manufacturers to rethink their facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results